Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025
Medtronic stock (NYSE: MDT) is in rally mode today, 18 November 2025, after the medical-device giant posted better‑than‑expected fiscal Q2 2026 results and raised its full‑year outlook, powered by booming demand for heart and diabetes technologies. As of late-morning U.S. trading, Medtronic shares were trading around $100–101, up roughly 4–5% on the day, after touching an intraday high near $102.40, according to market data from Investing.com and StockAnalysis. StockAnalysis+1 Reuters notes that the move pushed MDT to a more‑than‑three‑year high around $101 and put it on track for its biggest one‑day percentage gain in over five years, leaving the stock